Showing results (31-40 of 99) with videos related to
Sort By:
Pageof 10
Cancer Treatment Reviews|June 8, 2026
Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinomaTessa Hattenhauer, Rebekka Mispelbaum, Franz-Georg Bauernfeind, et al.Translational Oncology|August 28, 2015
Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread-Identification of a Promising Novel therapeutic targetSavita Bisht, Jens Nolting, Ute Schütte, et al.The Prostate|October 4, 2019
The value of tumor markers in men with metastatic prostate cancer undergoing [<sup>177</sup> Lu]Lu-PSMA therapyAnna Yordanova, Paula Linden, Stefan Hauser, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2018
Outcome and safety of rechallenge [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic prostate cancerAnna Yordanova, Paula Linden, Stefan Hauser, et al.Plos One|August 11, 2012
Detection of IGF2BP3, HOXB7, and NEK2 mRNA expression in brush cytology specimens as a new diagnostic tool in patients with biliary stricturesHans Dieter Nischalke, Volker Schmitz, Carolin Luda, et al.Journal of Cancer Research and Clinical Oncology|September 16, 2021
Blastic plasmacytoid dendritic-cell neoplasia: a challenging case reportRuth-Miriam Koerber, Stefanie A E Held, Maria Vonnahme, et al.Journal of Nanobiotechnology|July 13, 2016
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapiesSavita Bisht, Martin Schlesinger, Alexander Rupp, et al.Oncotargets and Therapy|October 19, 2017
Theranostics in nuclear medicine practiceAnna Yordanova, Elisabeth Eppard, Stefan Kürpig, et al.Molecular Imaging|April 21, 2007
Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancerCatherine A Foss, James J Fox, Georg Feldmann, et al.Gut|November 3, 2009
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancerVolker Fendrich, Nai-Ming Chen, Meike Neef, et al.Pageof 10